Hepatoprotective potential of anthocyanins from purple highland barley bran against non-alcoholic fatty liver disease through gut-liver axis
Key Points
Hepatoprotective effects have been observed due to anthocyanins from barley bran, indicating potential benefits for liver health.
In experimental models, anthocyanins effectively reduced biomarkers of non-alcoholic fatty liver disease, leading to improved outcomes over a defined period.
Analysis of the gut-liver axis highlights the complex interactions that anthocyanins facilitate, supporting liver function through gut health.
Implications suggest dietary anthocyanins may offer a natural intervention strategy for managing liver diseases, warranting further validation and studies.